Description
IGF::CT::IGF BLOOD AND BLOOD PRODUCTS
First action · last action
2014-10-01 · 2014-12-15
Transactions
3
First transaction's obligation
$122,802
Base + all options value (sum of deltas)
$104,101
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$122,802= $122,802
- Mod P000012014-10-31+$0= $122,802
- Mod P000022014-12-15-$18,701= $104,101
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$122,802 | $122,802 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS |
| Mod P00001· EXERCISE AN OPTION | 2014-10-31 | +$0 | $122,802 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS |
| Mod P00002· FUNDING ONLY ACTION | 2014-12-15 | −$18,701 | $104,101 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI W21CGPLB1JN6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0313 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $79,228 | FY2026 |
| 36C25626N0271 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $956,691 | FY2026 |
| 36C25726N0033 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $116,876 | FY2026 |
| 36C25926N0045 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $1,290,000 | FY2026 |
| 36C25726D0008 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25625N0277 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $559,381 | FY2025 |
Other recipients under Q301 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25616F0057 | LABORATORY CORPORATION OF AMERICA | 256-NETWORK CONTRACT OFFICE 16 | $223,705 | FY2016 |
| VA25616F0030 | LABORATORY CORPORATION OF AMERICA | 256-NETWORK CONTRACT OFFICE 16 | $20,669 | FY2016 |
| VA25615F1560 | QUEST DIAGNOSTICS TB LLC | 256-NETWORK CONTRACT OFFICE 16 | $20,160 | FY2016 |
| VA25616F0032 | ORTHO-CLINICAL DIAGNOSTICS, INC | 256-NETWORK CONTRACT OFFICE 16 | $25,732 | FY2016 |
| VA25616F0023 | LABORATORY CORPORATION OF AMERICA | 256-NETWORK CONTRACT OFFICE 16 | $21,717 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25615C0003_3600_-NONE-_-NONE- · retrieved 2026-09-26.